FCHSOTCServices-Medical LaboratoriesUS GAAP · USD

First Choice Healthcare Solutions, Inc.

First Choice Healthcare Solutions, Inc. is a U.S. healthcare services company in transition from its legacy orthopedic and physical therapy business toward a network of functional health and wellness clinics. Its planned model centers on personalized care services such as medical weight loss, hormone replacement, anti-aging, regenerative medicine, and pharmacy services in selected high-growth U.S. markets.

Liikevoitto (EBIT)−2,7milj. USD
−107,2 %v/v
Nettotulos−7,0milj. USD
−80,9 %v/v
Vapaa kassavirta−0,5milj. USD
+69,3 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2016–2025

−8−6−4−202milj. USD2016: EBIT 0,14 milj. USD20162017: EBIT −4,4 milj. USD20172022: EBIT −7,0 milj. USD20222023: EBIT −2,4 milj. USD20232024: EBIT −1,3 milj. USD20242025: EBIT −2,7 milj. USD2025−2,7
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Functional health clinics45 %

Clinic-based personalized care services including preventive care, functional medicine, hormone therapy, and wellness treatments.

Medical weight loss20 %

Prescription-based and programmatic weight management services aimed at obesity reduction and lifestyle improvement.

Pharmacy services20 %

Compounding and non-insurance pharmacy offerings, including subscription-based pricing for recurring customers.

Legacy rehabilitative services5 %

Residual orthopedic and physical therapy services that the company plans to terminate over time.

Adjunct wellness services10 %

Nutrition coaching, diagnostics, behavioral wellness, and medi-spa style offerings that support the core clinic model.

Asiakkaat

The company targets individuals seeking personalized healthcare beyond standard primary care, especially patients interested in weight loss, hormone optimization, anti-aging, and wellness services. It also serves patients who want recurring pharmacy support and bundled clinic services, often in urban and suburban markets where nurse practitioner-led care is more accepted.

Personalized care patients

Individuals buying clinic visits and treatment plans for preventive care, functional medicine, and wellness optimization.

Medical weight loss patients

Patients using prescription and program-based weight management services to address obesity and related health goals.

Hormone therapy and sexual health patients

Men and women seeking bio-identical hormone replacement, sexual health, and related specialty care.

Pharmacy customers

Recurring users of non-insurance pharmacy and compounded medications, including subscription members.

Legacy rehab patients

Residual orthopedic and physical therapy patients served while the company exits its older business model.

Strategia

Management is repositioning the company away from legacy orthopedic services and toward a national chain of functional health and wellness clinics. The strategy depends on acquiring or building clinics, repairing referral relationships, reducing costs, and adding pharmacy-led recurring revenue in markets with favorable nurse practitioner rules.

Transition to functional health clinicsLyhyt aikaväli

The legacy orthopedic model has been discontinued and the new model is the basis for future growth.

Expand into selected high-growth U.S. marketsKeskipitkä aikaväli

Management wants markets with strong demand and favorable nurse practitioner practice rules.

Build recurring pharmacy revenueKeskipitkä aikaväli

Pharmacy subscriptions and compounded medications can improve repeat business and patient retention.

Reduce operating costs and improve cash flowLyhyt aikaväli

The company has a going-concern issue and needs lower overhead to fund expansion.

Maantiede

The company is U.S.-focused and is building its next phase around states that allow full practice authority for nurse practitioners. Management specifically highlighted northeast and southwest Florida and Minnesota for initial expansion, with Denver and Phoenix under evaluation for future growth.

Riskit

The company faces substantial execution and financing risk because it is still rebuilding its business model and has limited operating history in the new clinic format. It also faces healthcare-specific risks around regulation, payor relationships, privacy, and pharmacy supply chain reliability, all of which can directly affect patient volume, compliance, and margins.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Going-concern and capital access1Execution risk in new clinic strategy2Referral and reputation damage3Pharmacy supply chain disruption4Healthcare privacy and regulatory compliance5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Going-concern and capital accessVaikutus: KriittinenTodennäköisyys: Korkea

    The company has recurring losses and negative operating cash flow, so it may need new equity or debt to fund expansion.

    Kohdistuu: Business development and clinic rollout

  2. Execution risk in new clinic strategyVaikutus: KorkeaTodennäköisyys: Korkea

    Management is pivoting away from a legacy model, and patient acquisition, branding, and clinic economics are unproven at scale.

    Kohdistuu: Clinic buildout and patient panel growth

  3. Referral and reputation damageVaikutus: KorkeaTodennäköisyys: Korkea

    The company disclosed prior litigation and reputational harm that affected employees and referral sources.

    Kohdistuu: Patient acquisition and provider relationships

  4. Pharmacy supply chain disruptionVaikutus: KorkeaTodennäköisyys: Kohtalainen

    A single compounding pharmacy serving multiple clinics could face ingredient shortages or logistics issues that interrupt service.

    Kohdistuu: Compounded medications and subscription services

  5. Healthcare privacy and regulatory complianceVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    HIPAA, HITECH, and state rules govern protected health information and can create penalties and added costs.

    Kohdistuu: Patient data handling and clinical operations

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition and discontinued services

The company reported only nominal revenue and said services were discontinued in 2023, so revenue trends are not representative of the future model.

Vaikutus: Makes top-line comparability and run-rate analysis difficult

Stock-based compensation and fair value estimates

Management identified stock fair value and stock-based compensation as significant estimates.

Vaikutus: Can materially affect operating expenses and net loss

Deferred taxes and credit loss allowances

These estimates depend on future profitability and collectability assumptions.

Vaikutus: Can change reported assets, expenses, and equity

Lease accounting

Clinic expansion through leased sites will increase right-of-use assets and lease liabilities.

Vaikutus: Affects leverage, EBITDA-like metrics, and fixed-cost burden

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026